Skip to content

Absci Corp

ABSI· NasdaqCore metricsCIK 1672688

Commercial physical & biological research16 peers

Last sale
Nov 12, 2026 · -9.38%
Market cap
$1.58B
172.75M shares
Filings
364
$304.00K
Q3 2026−38.2% FY25 yoy
-$33.30M
Q3 2026N/M FY25 yoy
-$34.99M
Q3 2026N/M FY25 yoy
-$83.38M
Q3 2026derivedN/M FY25 yoy
-$0.19
Q3 2026N/M FY25 yoy
$13.36M
Q3 2026−51.4% FY25 yoy
$1.58B
—
1060.6×
7.2×
-7.13%
—

Twelve months to Sep 30, 2026 · derived

Price

$9.13+165.41%+$5.69past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$2.80MFY 2025
$5.75M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$2,800,000reported
FY 20242024-12-31$4,534,000reported
FY 20232023-12-31$5,718,000reported
FY 20222022-12-31$5,747,000reported
FY 20212021-12-31$4,782,000reported
FY 20202020-12-31$4,780,000reported

Commercial physical & biological research

Absci Corp is the 11th largest of the 17 covered companies the SEC files under this code, by revenue. SIC 8731

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Absci Corp · CIK 1672688 · Engraved from SEC EDGAR